Steve G. Peters, M.D., studies late-stage lung diseases, risk factors and outcomes of transplantation, management of critically ill patients, and pulmonary complications after hematopoietic stem cell transplant.
Dr. Peters also has a research interest in applied clinical informatics — the study of the interactions among technology, medical science, workflow and processes in the delivery of effective and efficient care.
- Lung transplantation complications. Dr. Peters studies acute and chronic rejection, infections, drug toxicity and malignancies after lung transplant.
- Pulmonary complications of hematopoietic stem cell transplantation. Dr. Peters studies infections and acute and chronic noninfectious conditions after hematopoietic stem cell transplant.
- Applied clinical informatics. Dr. Peters studies the impact of computerized clinical decision support at the point of care on outcomes of acute and chronic illness.
Significance to patient care
Conditions such as chronic obstructive lung disease, pulmonary fibrosis and cystic fibrosis are common indications for lung transplantation. Long-term lung transplant outcomes are modest and there are many potential areas for improvement, including patient selection and preparation, transplant immune suppression, and better management of complications.
By studying outcomes of acute and chronic respiratory failure, Dr. Peters hopes to find ways to modify and improve these outcomes, including better recognition, early intervention and new therapies. For complex management of patients after cardiothoracic or hematopoietic stem cell transplant, there are many opportunities to improve the management of pulmonary complications.
In the field of informatics, Dr. Peters hopes the application of technology to manage massive amounts of data and information will deliver appropriate and timely knowledge at the point of clinical care.